Login / Signup

Evaluation of dupilumab on the disease burden in children and adolescents with atopic dermatitis: A population-based cohort study.

Serena Yun-Chen TsaiJonathan M GaffinElena B HawrylukHana B RuranLisa M BartnikasMichiko K OyoshiLynda C SchneiderWanda PhipatanakulKevin Sheng-Kai Ma
Published in: Allergy (2024)
Treatment with dupilumab compared to systemic agents resulted in reductions in AD-related comorbidities in pediatric patients.
Keyphrases
  • atopic dermatitis
  • risk factors